
August 8, 2023
RegMed Investors’ (RMi) pre-open: earnings, earnings and more earnings
August 7, 2023
RegMed Investors’ (RMi) pre-open: after a losing week
August 4, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector slowly fades after earnings’ LPS (loss-per-share) reports
August 4, 2023
RegMed Investors’ (RMi) pre-open: jobs data
August 3, 2023
RegMed Investors’ (RMi) closing bell: earnings LPS (loss-per-share) still coming enabling many sectors’ shares pricing decline
August 3, 2023
RegMed Investors’ (RMi) pre-open: chose; Rock, paper or scissors
August 2, 2023
RegMed Investors’ (RMi) closing bell: consensus, revenue beats, misses and share pricing response
August 2, 2023
RegMed Investors’ (RMi) pre-open: Impact of rating actions and earnings
August 1, 2023
RegMed Investors’ (RMi) closing bell: waiting and wanting earnings LPS (loss-per-share) having started to be over
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors